This post was originally published on this site
MARKETWATCH FRONT PAGE
Will the U.S. stock market retest bear-market lows put in on March 23? That is perhaps the most prevalent question on Wall Street. See full story.
FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment
The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment. See full story.
Amazon’s CEO tells investors ‘you may want to take a seat,’ as he explains why the company will spend ‘entirety’ of $4 billion profit
Amazon unsurprisingly topped expectations for sales, in the era of the COVID-19 pandemic, but it was comments from CEO Jeff Bezos, in his written statement along with the quarterly update, that really drew the focus on Wall Street Thursday evening. See full story.
Here’s Warren Buffett’s chance to offer coronavirus-shaken investors his insights on a topsy-turvy stock market
If Warren Buffett has any words of comfort or warning for stock-market investors dazed and confused by the COVID-19 pandemic, they will presumably hear them on Saturday. See full story.
Why millions of older workers will pay a big financial price—forever—from the coronavirus
Even in good times, age discrimination is rampant See full story.
MARKETWATCH PERSONAL FINANCE
Andre Shakti majored in deaf studies and psychology at college, helps to support her father, and works as a stripper, dominatrix and sex educator. See full story.
